Skip to content

Feasibility and Performance Evaluation for INVSENSOR00024

Feasibility and Performance Evaluation of INVSENSOR00024

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03570255
Enrollment
28
Registered
2018-06-26
Start date
2018-06-25
Completion date
2019-11-08
Last updated
2020-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Evaluation of SpO2 Performance

Brief summary

This is a prospective, non-randomized, single arm study design to evaluate SpO2 performance of the RD SET Neo investigational pulse oximeter sensors in the neonatal population using convenience sampling in a clinical environment. The initial subjects under Protocol Version 1 were enrolled as part of a feasibility study to verify the design changes to the sensor are correct. The study protocol was amended with Protocol Version 2 to enroll a group of subjects that will be used to evaluate clinical performance for submission to regulatory agencies.

Interventions

All subjects are enrolled in the experimental group and receive the RD SET Neo SpO2 sensor.

Sponsors

Masimo Corporation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
No minimum to 1 Months
Healthy volunteers
Yes

Inclusion criteria

* Less than or equal to 1 month of age * Weight \<3kg * Subjects admitted with standard of care (SOC) arterial blood sampling line already in place

Exclusion criteria

* Subjects with underdeveloped skin * Subjects with abnormalities at the planned application sites that would interfere with system measurements * Subjects with known allergic reactions to foam/rubber products and adhesive tape * Deformities of limbs, absence of feet, sever edema, and other at the discretion of the Principal Investigator

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Oxygen Saturation (SpO2) Measurement by RMS Calculationup to 8 hoursAccuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the root mean square (RMS) error value. In order to obtain the RMS value, the blood oxygen saturation measurement form a laboratory pulse Co-Oximeter is subtracted from the pulse oximeter oxygen saturation measurement for each sample, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the RMS Error value.

Countries

United States

Participant flow

Participants by arm

ArmCount
RD SET Neo SpO2
All subjects enrolled in the study will receive the investigational sensor (RD SET Neo SpO2) for evaluation of SpO2. RD SET Neo SpO2: All subjects are enrolled in the experimental group and receive the RD SET Neo SpO2 sensor.
28
Total28

Baseline characteristics

CharacteristicRD SET Neo SpO2
Age, Categorical
<=18 years
28 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
3 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
1 Participants
Race (NIH/OMB)
Unknown or Not Reported
10 Participants
Race (NIH/OMB)
White
14 Participants
Region of Enrollment
United States
28 participants
Sex: Female, Male
Female
10 Participants
Sex: Female, Male
Male
18 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 28
other
Total, other adverse events
0 / 28
serious
Total, serious adverse events
0 / 28

Outcome results

Primary

Accuracy of Oxygen Saturation (SpO2) Measurement by RMS Calculation

Accuracy will be determined by comparing the noninvasive blood oxygen saturation measurement of the pulse oximeter to that obtained from a blood sample and calculating the root mean square (RMS) error value. In order to obtain the RMS value, the blood oxygen saturation measurement form a laboratory pulse Co-Oximeter is subtracted from the pulse oximeter oxygen saturation measurement for each sample, the average of this difference is computed as the bias. The standard deviation of the differences is computed as the precision. The square root of the sum of the squares of bias and precision is computed as the RMS Error value.

Time frame: up to 8 hours

Population: Subject 7 \& 11: Protocol deviation Subject 19 \& 26: Outlier data points Subject 5: Removed per ISO standard for SpO2 equal to 100.

ArmMeasureValue (NUMBER)
RD SET Neo SpO2Accuracy of Oxygen Saturation (SpO2) Measurement by RMS Calculation2.1 percent of oxygen saturated hemoglobin

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026